FDA sets up drug quality website; EMA issues final biosimilars guidance; Xellia not going to Sarasota, FL;

> The FDA has launched a website about its drug quality sampling and testing programs. More from the FDA

> DPT Laboratories has added a new filling line to a facility in San Antonio, TX. Release

> The FDA is frustrated that the Internet Corporation for Assigned Names and Numbers (ICANN) won't shut down sites selling counterfeit drugs. Story (sub. req.)

> The European Medicines Agency has issued its final guidance for developing biosimilars. Story

And Finally... Denmark's Xellia Pharmaceuticals is not going to build a $200 million manufacturing facility in Sarasota, FL. Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.